Company news
Envoy Medical, Inc. (NASDAQ:COCH) news
Envoy Medical, Inc. news releases on 6ix. Latest, Sep 22, 2026: Envoy Medical Announces New Patents, Further Expanding Global Patent Portfolio
Press releases & updates
Envoy Medical Announces New Patents, Further Expanding Global Patent Portfolio
September 22, 2026
Envoy Medical to Present at the H.C. Wainwright 28th Annual Global Investment Conference on September 14th-16th
September 2, 2026
Envoy Medical Reports Second Quarter 2026 Results and Achieves Key Regulatory and Clinical Milestones
August 10, 2026
Envoy Medical Surpasses Three-Month Visit Milestone for All 56 Patients in Pivotal Clinical Trial
July 21, 2026
Envoy Medical Reports Positive 12-Month Data Showing Continued Improvement in Speech Perception in Study of First-of-Its-Kind Fully Implanted Cochlear Implant
July 14, 2026
Envoy Medical Submits First Module of Modular Premarket Approval Application to the U.S. Food and Drug Administration for Breakthrough-Designated Device
June 30, 2026
Envoy Medical Terminates At-the-Market (ATM) Equity Facility
June 25, 2026
Envoy Medical to Present at Investor Conferences on June 25th
June 18, 2026
Envoy Medical to Present at Planet MicroCap Conference Las Vegas on June 16th-18th
June 3, 2026
Envoy Medical (NASDAQ:COCH) Signs Multi-Part Series With New to The Street
June 1, 2026
Envoy Medical Announces New Patents Expanding Intellectual Property Portfolio in Fully Implanted Hearing Technology
May 20, 2026
Envoy Medical Reports Landmark Accomplishments, Advancing Toward FDA Approval of First-of-Its-Kind Fully Implanted Cochlear Implant
May 11, 2026
Envoy Medical Highlights First Clinical Data Presentations from Pivotal Clinical Study of Fully Implanted Acclaim(R) Cochlear Implant
April 28, 2026
Envoy Medical Reaches Critical Milestone in Pivotal Clinical Trial of Fully Implanted Acclaim(R) Cochlear Implant
April 21, 2026
Envoy Medical Appoints Chas McKhann to Board of Directors
April 15, 2026
Envoy Medical Announces First Patients Successfully Reaching 12-Month Endpoint in Pivotal Clinical Trial for Fully Implanted Cochlear Implant
March 31, 2026
Envoy Medical Reports Full Year 2025 Financial Results
March 23, 2026
Envoy Medical Completes Enrollment of Pivotal Clinical Trial Evaluating First-Of-Its-Kind Fully Implanted Cochlear Implant
March 10, 2026
Envoy Medical Regains Compliance with Nasdaq Listing Requirement
February 24, 2026
Envoy Medical Secures Three New Patents Strengthening Competitive Position in the Fully Implanted Hearing Space
February 22, 2026
Envoy Medical Provides Business Update Following Transformative Financing and Positive Progress in Clinical Trial
February 19, 2026
Envoy Medical Nears Completion of Enrollment in Pivotal Clinical Trial of Fully Implanted Acclaim(R) Cochlear Implant
February 17, 2026
Envoy Medical Announces Closing of Up to $78.0 Million Upsized Public Offering
February 12, 2026
Envoy Medical Announces Pricing of Up to $78.0 Million Upsized Public Offering
February 11, 2026
Envoy Medical to Present at the Small Cap Growth Virtual Investor Conference February 5
January 29, 2026
Envoy Medical Reaches Enrollment Milestone in Pivotal Clinical Study of Fully Implanted Acclaim(R) Cochlear Implant
December 18, 2025
Envoy Medical Secures New Australian Patent for Cochlear Implant Innovation Aimed at Enhancing Input Signal-to-Noise Ratio
December 16, 2025
Envoy Medical Completes First Set of Activations in Final Stage of Pivotal Clinical Study for its First-Of-Its-Kind Fully Implanted Acclaim(R) Cochlear Implant
December 10, 2025
Envoy Medical to Host Fireside Chat with CEO Brent Lucas and the First Acclaim(R) Cochlear Implant Patient
December 4, 2025
Envoy Medical Announces the Grant of Its 40th U.S. Patent
December 2, 2025
Envoy Medical Secures New U.S. Patent for Innovative Cochlear Implant System Featuring a Removable Earplug Sensor and an Implanted Battery
November 20, 2025
Envoy Medical Achieves Six-Month Milestone with First 10 Patients in Acclaim(R) Cochlear Implant Clinical Trial
November 18, 2025
Envoy Medical Reports Third Quarter 2025 Financial and Operational Results
November 10, 2025
Envoy Medical Announces First Three Patients Enrolled in Final Stage of Acclaim(R) Cochlear Implant Pivotal Clinical Trial
November 4, 2025
Envoy Medical Marks Three-Year Anniversary of First Patient Receiving Its Breakthrough Fully Implanted Cochlear Implant
October 29, 2025
Envoy Medical Receives Positive Listing Determination from NASDAQ
October 27, 2025
Envoy Medical to Present at the Virtual Technology Investor Conference on October 28th
October 23, 2025
Envoy Medical Announces Closing of Up to $16 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
October 9, 2025
Envoy Medical Announces up to $16 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
October 8, 2025
Envoy Medical Receives FDA Approval to Expand Its Pivotal Clinical Trial to Final Stage Based on Submission of Promising Three-Month Data
October 7, 2025
Envoy Medical to Participate in the American Academy of Otolaryngology Head and Neck Surgery (AAO-HNSF) Conference on October 11th-14th
October 1, 2025
Envoy Medical Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
September 25, 2025
Envoy Medical Advances Commercialization Planning for Breakthrough Hearing Device as FDA Clinical Trial Remains On Track
September 24, 2025
Envoy Medical Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
September 22, 2025
Envoy Medical Expands Patent Portfolio by Securing Additional European Patent for Breakthrough Cochlear Implant Technology
September 19, 2025
Envoy Medical Issues Letter to Shareholders and Provides Update on Recent Accomplishments
September 10, 2025
Envoy Medical Secures Four New Global Patents, Expanding Its Leadership Position in Fully Implantable Hearing Technology
September 9, 2025
Envoy Medical to Present at the H.C. Wainwright 27th Annual Global Investment Conference on September 8-10, 2025
September 8, 2025
Envoy Medical Successfully Reaches Three-Month Follow-Up Milestone in Clinical Trial of the Acclaim Fully Implanted Cochlear Implant
September 3, 2025
Envoy Medical Extinguishes over $32 Million in Debt, Strengthening Balance Sheet; Announces Retirement of Glen A. Taylor from Board
August 26, 2025